Tiotropium Powder Inhalation 18 mcg
Tiotropium Powder Inhalation 18 mcg is a long-acting bronchodilator used for the maintenance treatment of chronic respiratory disorders. It helps improve breathing by relaxing the muscles around the airways, allowing better airflow to the lungs and reducing symptoms such as shortness of breath, wheezing, and chest tightness.
Composition
Each capsule contains:
Tiotropium Bromide Monohydrate equivalent to Tiotropium 18 mcg
Suitable inhalation-grade excipients
Therapeutic Category
Respiratory Medicine
Long-Acting Muscarinic Antagonist (LAMA)
Bronchodilator
COPD Maintenance Therapy
Treatment Applications
Tiotropium Powder Inhalation 18 mcg is indicated for:
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Bronchitis
Emphysema
Long-term airway obstruction management
Maintenance treatment of respiratory disorders
Reduction of COPD exacerbations
Improvement of lung function and breathing capacity
Benefits of Tiotropium Inhalation
Provides 24-hour bronchodilation
Improves airflow in the lungs
Reduces breathlessness during daily activities
Helps decrease COPD flare-ups
Enhances patient quality of life
Convenient once-daily dosing
Supports long-term respiratory management
Dosage and Administration
Use only as directed by a qualified healthcare professional.
Generally administered through a compatible dry powder inhalation device.
The capsule is intended for inhalation only and should not be swallowed.
Regular daily use is recommended for maximum therapeutic benefit.
Storage Instructions
Store below 25°C.
Protect from moisture and direct sunlight.
Keep capsules in original packaging until use.
Keep out of reach of children.
Do not freeze.
South Africa Respiratory Market Focus
Respiratory disorders remain a major healthcare concern across South Africa due to environmental pollution, smoking-related diseases, occupational lung conditions, and seasonal respiratory infections.
High-Demand South African Provinces for Respiratory Products
Gauteng
Major healthcare centers and respiratory clinics create strong demand for COPD and asthma therapies.
Western Cape
Large patient population requiring long-term respiratory disease management.
KwaZulu-Natal
Growing demand for inhalation therapies due to chronic respiratory conditions.
Eastern Cape
Increasing use of maintenance respiratory medicines in public and private healthcare sectors.
Free State
Significant demand for COPD and chronic bronchitis treatment products.
Mpumalanga
Industrial and mining regions contribute to respiratory healthcare requirements.
Limpopo
Growing healthcare infrastructure supporting respiratory treatment availability.
North West
Demand for affordable and effective inhalation therapies.
Northern Cape
Expansion of respiratory care services and chronic disease management.
Cordium Pharmaceuticals Pvt Ltd – Global Respiratory Product Exporter
Cordium Pharmaceuticals Pvt Ltd supplies high-quality respiratory products to international distributors, pharmacies, hospitals, wholesalers, healthcare institutions, and importers.
For Product Enquiries:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
We support export documentation, private labeling, bulk supply, and international distribution requirements for respiratory healthcare products.